These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Is routine influenza immunization indicated for people over 65 years of age? An opposing view. Frame PS. J Fam Pract; 1988 Feb; 26(2):215-7. PubMed ID: 3339326 [Abstract] [Full Text] [Related]
10. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [Abstract] [Full Text] [Related]
11. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers. de Bruijn IA, Nauta J, Gerez L, Palache AM. Virus Res; 2004 Jul; 103(1-2):139-45. PubMed ID: 15163502 [Abstract] [Full Text] [Related]
13. Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan. Wang ST, Lee LT, Chen LS, Chen TH. Vaccine; 2005 Mar 14; 23(16):1973-80. PubMed ID: 15734070 [Abstract] [Full Text] [Related]
15. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ. Vaccine; 2008 Jun 02; 26(23):2841-8. PubMed ID: 18462851 [Abstract] [Full Text] [Related]
17. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Szucs TD, Müller D. Vaccine; 2005 Oct 17; 23(43):5055-63. PubMed ID: 16046035 [Abstract] [Full Text] [Related]